President and Chief Executive Officer
Arena Pharmaceuticals is focused on delivering solutions for cardiovascular, central nervous system, inflammatory and metabolic diseases.
As of May 2016, Amit Munshi is President and CEO of Arena Pharmaceuticals Inc. where he is leading a transformation of the company around three novel, proprietary Phase 2 compounds. From May 2012 to May 2016, Amit Munshi was President and CEO of EPIRUS (NASDAQ:EPRS) focused on the development of biosimilars globally. Previously he was the President and CEO of Percivia LLC, a Royal DSM / Crucell joint venture developing biosimilar molecules for emerging markets. Prior to Percivia, Munshi was a co-founder and Chief Business Officer of Kythera Biopharmaceuticals Inc. (NASDAQ: KYTH), a company focused on novel prescription therapeutics in the field of aesthetic medicine. Mr. Munshi spent 8 years at Amgen Inc. Mr. Munshi's positions at Amgen included, General Manager of Amgen’s European Nephrology Business based in Switzerland, responsibility for Amgen’s inflammation marketing, and responsibility for global new product planning.Munshi has previously also held positions in sales, market research, marketing, managed care, and product licensing during tenures at Astra Merck and IOLAB Corporation (a J&J Company).He is a co-founder and former Board member at Nephrian Inc. and a former Board member at Cynvenio Biosystems, Inc. He is currently, co-founder, and member of the Board of Directors at Oxeia Biopharmaceuticals, and a member of the Board of Directors of Cytrellis BIosystems.Mr. Munshi received a MBA from The Peter Drucker Graduate School of Management at Claremont Graduate University and holds a BA in History and a BS in Economics from the University of California, Riverside.Specialties: Corporate start up and turnarounds, General management, Sales & Marketing, Business development (Licensing, M&A), Corporate Strategy, Fund Raising